☆ 4.7 Article

Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION Network

JOURNAL OF INFECTIOUS DISEASES (2023)

Related references

Note: Only part of the references are listed.

Article Immunology

Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems

Holly C. Groom et al.

Summary: This study investigated the data receiving and integration status of eight Vaccine Safety Datalink (VSD) sites, and found that COVID-19 vaccine data can be timely received and integrated, which lays a solid foundation for vaccine safety quality assessments within the VSD.

VACCINE (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

Mark G. Thompson et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Add to Collection

Article Immunology

Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors

Margaret K. Doll et al.

Summary: Vaccine effectiveness estimates for influenza and COVID-19 may be biased due to correlated vaccination behaviors, and it is important to address this bias in test-negative studies.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022

Jessie R. Chung et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Add to Collection

Letter Medicine, General & Internal

Association between Covid-19 Vaccination and Influenza Vaccination Rates

Richard K. Leuchter et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Influenza Activity and Composition of the 2022–23 Influenza Vaccine — United States, 2021–22 Season

Angiezel Merced-Morales et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Add to Collection

Article Immunology

Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015-2018

Mark W. Tenforde et al.

Summary: This study compared the effectiveness of influenza vaccination between inpatient and outpatient networks in the US, finding that inpatients were older and had more high-risk conditions than outpatients. The overall vaccine effectiveness across seasons was 31% for outpatients and 36% for inpatients, with some differences observed in strain-specific VE between the two groups.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Comparative Effectiveness of Influenza Vaccines Among US Medicare Beneficiaries Ages 65 Years and Older During the 2019-2020 Season

Hector S. Izurieta et al.

Summary: In this study, we analyzed the relative vaccine effectiveness of different types of influenza vaccines in preventing hospital encounters among Medicare beneficiaries aged >= 65 years during the 2019-2020 season. The results showed that recombinant quadrivalent vaccine was moderately more effective than other vaccines during the season, while high-dose trivalent and adjuvanted trivalent vaccines were more effective than quadrivalent vaccines, emphasizing the contributions of antigen amount and adjuvant use to vaccine effectiveness.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019-2020

Mark W. Tenforde et al.

Summary: This study evaluated the effectiveness of the 2019-2020 influenza vaccine against influenza-associated hospitalization in the United States, showing a 41% reduction in risk of hospitalized influenza illness. Among the two major A(H1N1)pdmO9 subgroups, one subgroup had a vaccine effectiveness of 59%, while no effectiveness was observed in the other subgroup.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021

Peter J. Embi et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Immunology

Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study

Carlos G. Grijalva et al.

Summary: This study evaluated the effectiveness of the influenza vaccine in preventing severe acute respiratory infection associated with influenza during the 2019-2020 season. The results showed that the vaccine reduced severe influenza-associated illness by 32%, with higher effectiveness observed in young adults.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

M. G. Thompson et al.

Summary: A study with a test-negative design analyzed 41,552 admissions to 187 hospitals and 21,522 visits to 221 EDs or urgent care clinics. The mRNA-based vaccines (>= 14 days after the second dose) were highly effective against SARS-CoV-2 infection leading to hospitalization (89%), ICU admission (90%), or an urgent care visit (91%).

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic — United States, 2020–2021

Sonja J. Olsen et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Immunology

Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018-2019

Hector S. Izurieta et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Decreased Influenza Activity During the COVID-19 Pandemic — United States, Australia, Chile, and South Africa, 2020

Sonja J. Olsen et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Add to Collection

Article Immunology

Intraseason Waning of Influenza Vaccine Effectiveness

G. Thomas Ray et al.

CLINICAL INFECTIOUS DISEASES (2019)

Add to Collection

Article Immunology

Influenza Vaccine Effectiveness: Defining the H3N2 Problem

Edward A. Belongia et al.

CLINICAL INFECTIOUS DISEASES (2019)

Add to Collection

Article Immunology

Birth Cohort Effects in Influenza Surveillance Data: Evidence That First Influenza Infection Affects Later Influenza-Associated Illness

Alicia P. Budd et al.

JOURNAL OF INFECTIOUS DISEASES (2019)

Add to Collection

Review Immunology

Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies

Barnaby Young et al.

JOURNAL OF INFECTIOUS DISEASES (2018)

Add to Collection

Article Immunology

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons

Kate Russell et al.

VACCINE (2018)

Add to Collection

Article Immunology

Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015

Danuta M. Skowronski et al.

JOURNAL OF INFECTIOUS DISEASES (2017)

Add to Collection

Article Multidisciplinary Sciences

Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains

Seth J. Zost et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Add to Collection

Article Microbiology

A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine

Nicholas C. Wu et al.

PLOS PATHOGENS (2017)

Add to Collection

Letter Immunology

Pooling and the Potential Dilution of Repeat Influenza Vaccination Effects

Danuta M. Skowronski et al.

CLINICAL INFECTIOUS DISEASES (2017)

Add to Collection

Review Infectious Diseases

Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies

Edward A. Belongia et al.

LANCET INFECTIOUS DISEASES (2016)

Add to Collection

Review Immunology

Immunosenescence: emerging challenges for an ageing population

Danielle Aw et al.

IMMUNOLOGY (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.